Healthcare Finance News July 20, 2022
Equitable Breakthroughs in Medicine Development will get more underrepresented patients involved in the R&D of medical treatments.
The Pharmaceutical Research and Manufacturers of America is funding a clinical trial initiative to enhance diversity, which has been lacking in the development of new drugs.
The initial $10 million grant will fund an 18-month pilot at ten community sites located in the southern United States.
PhRMA is collaborating on the Equitable Breakthroughs in Medicine Development with the Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center at Morehouse School of Medicine and Vanderbilt University Medical Center.
WHY THIS MATTERS
Clinical trials have long been challenged in getting enough participation, particularly in getting a diverse population.